 | • レポートコード：GIR-107A12524 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、腫瘍創薬サービスのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腫瘍創薬サービスの種類別市場規模（識別サービス、認証サービス、リードジェネレーション・リード最適化サービス、その他）、用途別市場規模（研究所、製薬会社、バイオテクノロジー会社、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・腫瘍創薬サービスの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Charles River、Evotec、GE Healthcare Life Sciences、GenScript、Horizon Discovery、TCG Lifesciences、Zumutor、ChemPartner、Aquila BioMedical、Onconova、Vichem Chemie、GVK Biosciences、NuChem Therapeutics、Syncom、Envigo、DiverChim、Aurora、HD Biosciences、WuXi AppTec ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：識別サービス、認証サービス、リードジェネレーション・リード最適化サービス、その他 ・用途別分析2016年-2026年：研究所、製薬会社、バイオテクノロジー会社、その他 ・腫瘍創薬サービスの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腫瘍創薬サービスのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腫瘍創薬サービスのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腫瘍創薬サービスの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腫瘍創薬サービスの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oncology Drug Discovery Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oncology Drug Discovery Services size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Oncology Drug Discovery Services market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Oncology Drug Discovery Services market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Identification Service
Authentication Service
Hit-to-lead and Lead Optimization Services
Others
Market segment by Application, can be divided into
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
Market segment by players, this report covers
Charles River
Evotec
GE Healthcare Life Sciences
GenScript
Horizon Discovery
TCG Lifesciences
Zumutor
ChemPartner
Aquila BioMedical
Onconova
Vichem Chemie
GVK Biosciences
NuChem Therapeutics
Syncom
Envigo
DiverChim
Aurora
HD Biosciences
WuXi AppTec
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Oncology Drug Discovery Services
1.2 Classification of Oncology Drug Discovery Services by Type
1.2.1 Overview: Global Oncology Drug Discovery Services Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Oncology Drug Discovery Services Revenue Market Share by Type in 2020
1.2.3 Identification Service
1.2.4 Authentication Service
1.2.5 Hit-to-lead and Lead Optimization Services
1.2.6 Others
1.3 Global Oncology Drug Discovery Services Market by Application
1.3.1 Overview: Global Oncology Drug Discovery Services Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Others
1.4 Global Oncology Drug Discovery Services Market Size & Forecast
1.5 Global Oncology Drug Discovery Services Market Size and Forecast by Region
1.5.1 Global Oncology Drug Discovery Services Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Oncology Drug Discovery Services Market Size by Region, (2016-2021)
1.5.3 North America Oncology Drug Discovery Services Market Size and Prospect (2016-2026)
1.5.4 Europe Oncology Drug Discovery Services Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Oncology Drug Discovery Services Market Size and Prospect (2016-2026)
1.5.6 South America Oncology Drug Discovery Services Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Oncology Drug Discovery Services Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology Drug Discovery Services Market Drivers
1.6.2 Oncology Drug Discovery Services Market Restraints
1.6.3 Oncology Drug Discovery Services Trends Analysis
2 Company Profiles
2.1 Charles River
2.1.1 Charles River Details
2.1.2 Charles River Major Business
2.1.3 Charles River Oncology Drug Discovery Services Product and Solutions
2.1.4 Charles River Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Charles River Recent Developments and Future Plans
2.2 Evotec
2.2.1 Evotec Details
2.2.2 Evotec Major Business
2.2.3 Evotec Oncology Drug Discovery Services Product and Solutions
2.2.4 Evotec Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Evotec Recent Developments and Future Plans
2.3 GE Healthcare Life Sciences
2.3.1 GE Healthcare Life Sciences Details
2.3.2 GE Healthcare Life Sciences Major Business
2.3.3 GE Healthcare Life Sciences Oncology Drug Discovery Services Product and Solutions
2.3.4 GE Healthcare Life Sciences Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GE Healthcare Life Sciences Recent Developments and Future Plans
2.4 GenScript
2.4.1 GenScript Details
2.4.2 GenScript Major Business
2.4.3 GenScript Oncology Drug Discovery Services Product and Solutions
2.4.4 GenScript Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 GenScript Recent Developments and Future Plans
2.5 Horizon Discovery
2.5.1 Horizon Discovery Details
2.5.2 Horizon Discovery Major Business
2.5.3 Horizon Discovery Oncology Drug Discovery Services Product and Solutions
2.5.4 Horizon Discovery Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Horizon Discovery Recent Developments and Future Plans
2.6 TCG Lifesciences
2.6.1 TCG Lifesciences Details
2.6.2 TCG Lifesciences Major Business
2.6.3 TCG Lifesciences Oncology Drug Discovery Services Product and Solutions
2.6.4 TCG Lifesciences Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 TCG Lifesciences Recent Developments and Future Plans
2.7 Zumutor
2.7.1 Zumutor Details
2.7.2 Zumutor Major Business
2.7.3 Zumutor Oncology Drug Discovery Services Product and Solutions
2.7.4 Zumutor Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Zumutor Recent Developments and Future Plans
2.8 ChemPartner
2.8.1 ChemPartner Details
2.8.2 ChemPartner Major Business
2.8.3 ChemPartner Oncology Drug Discovery Services Product and Solutions
2.8.4 ChemPartner Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 ChemPartner Recent Developments and Future Plans
2.9 Aquila BioMedical
2.9.1 Aquila BioMedical Details
2.9.2 Aquila BioMedical Major Business
2.9.3 Aquila BioMedical Oncology Drug Discovery Services Product and Solutions
2.9.4 Aquila BioMedical Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Aquila BioMedical Recent Developments and Future Plans
2.10 Onconova
2.10.1 Onconova Details
2.10.2 Onconova Major Business
2.10.3 Onconova Oncology Drug Discovery Services Product and Solutions
2.10.4 Onconova Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Onconova Recent Developments and Future Plans
2.11 Vichem Chemie
2.11.1 Vichem Chemie Details
2.11.2 Vichem Chemie Major Business
2.11.3 Vichem Chemie Oncology Drug Discovery Services Product and Solutions
2.11.4 Vichem Chemie Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Vichem Chemie Recent Developments and Future Plans
2.12 GVK Biosciences
2.12.1 GVK Biosciences Details
2.12.2 GVK Biosciences Major Business
2.12.3 GVK Biosciences Oncology Drug Discovery Services Product and Solutions
2.12.4 GVK Biosciences Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 GVK Biosciences Recent Developments and Future Plans
2.13 NuChem Therapeutics
2.13.1 NuChem Therapeutics Details
2.13.2 NuChem Therapeutics Major Business
2.13.3 NuChem Therapeutics Oncology Drug Discovery Services Product and Solutions
2.13.4 NuChem Therapeutics Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 NuChem Therapeutics Recent Developments and Future Plans
2.14 Syncom
2.14.1 Syncom Details
2.14.2 Syncom Major Business
2.14.3 Syncom Oncology Drug Discovery Services Product and Solutions
2.14.4 Syncom Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Syncom Recent Developments and Future Plans
2.15 Envigo
2.15.1 Envigo Details
2.15.2 Envigo Major Business
2.15.3 Envigo Oncology Drug Discovery Services Product and Solutions
2.15.4 Envigo Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Envigo Recent Developments and Future Plans
2.16 DiverChim
2.16.1 DiverChim Details
2.16.2 DiverChim Major Business
2.16.3 DiverChim Oncology Drug Discovery Services Product and Solutions
2.16.4 DiverChim Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 DiverChim Recent Developments and Future Plans
2.17 Aurora
2.17.1 Aurora Details
2.17.2 Aurora Major Business
2.17.3 Aurora Oncology Drug Discovery Services Product and Solutions
2.17.4 Aurora Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Aurora Recent Developments and Future Plans
2.18 HD Biosciences
2.18.1 HD Biosciences Details
2.18.2 HD Biosciences Major Business
2.18.3 HD Biosciences Oncology Drug Discovery Services Product and Solutions
2.18.4 HD Biosciences Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 HD Biosciences Recent Developments and Future Plans
2.19 WuXi AppTec
2.19.1 WuXi AppTec Details
2.19.2 WuXi AppTec Major Business
2.19.3 WuXi AppTec Oncology Drug Discovery Services Product and Solutions
2.19.4 WuXi AppTec Oncology Drug Discovery Services Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 WuXi AppTec Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oncology Drug Discovery Services Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Oncology Drug Discovery Services Players Market Share
3.2.2 Top 10 Oncology Drug Discovery Services Players Market Share
3.2.3 Market Competition Trend
3.3 Oncology Drug Discovery Services Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Oncology Drug Discovery Services Revenue and Market Share by Type (2016-2021)
4.2 Global Oncology Drug Discovery Services Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Oncology Drug Discovery Services Revenue Market Share by Application (2016-2021)
5.2 Oncology Drug Discovery Services Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Oncology Drug Discovery Services Revenue by Type (2016-2026)
6.2 North America Oncology Drug Discovery Services Revenue by Application (2016-2026)
6.3 North America Oncology Drug Discovery Services Market Size by Country
6.3.1 North America Oncology Drug Discovery Services Revenue by Country (2016-2026)
6.3.2 United States Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
6.3.3 Canada Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
6.3.4 Mexico Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Oncology Drug Discovery Services Revenue by Type (2016-2026)
7.2 Europe Oncology Drug Discovery Services Revenue by Application (2016-2026)
7.3 Europe Oncology Drug Discovery Services Market Size by Country
7.3.1 Europe Oncology Drug Discovery Services Revenue by Country (2016-2026)
7.3.2 Germany Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
7.3.3 France Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
7.3.5 Russia Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
7.3.6 Italy Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Oncology Drug Discovery Services Revenue by Type (2016-2026)
8.2 Asia-Pacific Oncology Drug Discovery Services Revenue by Application (2016-2026)
8.3 Asia-Pacific Oncology Drug Discovery Services Market Size by Region
8.3.1 Asia-Pacific Oncology Drug Discovery Services Revenue by Region (2016-2026)
8.3.2 China Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
8.3.3 Japan Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
8.3.4 South Korea Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
8.3.5 India Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
8.3.7 Australia Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Oncology Drug Discovery Services Revenue by Type (2016-2026)
9.2 South America Oncology Drug Discovery Services Revenue by Application (2016-2026)
9.3 South America Oncology Drug Discovery Services Market Size by Country
9.3.1 South America Oncology Drug Discovery Services Revenue by Country (2016-2026)
9.3.2 Brazil Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
9.3.3 Argentina Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Oncology Drug Discovery Services Revenue by Type (2016-2026)
10.2 Middle East & Africa Oncology Drug Discovery Services Revenue by Application (2016-2026)
10.3 Middle East & Africa Oncology Drug Discovery Services Market Size by Country
10.3.1 Middle East & Africa Oncology Drug Discovery Services Revenue by Country (2016-2026)
10.3.2 Turkey Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
10.3.4 UAE Oncology Drug Discovery Services Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Oncology Drug Discovery Services Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Oncology Drug Discovery Services Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Oncology Drug Discovery Services Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Oncology Drug Discovery Services Revenue (USD Million) by Region (2016-2021)
Table 5. Global Oncology Drug Discovery Services Revenue Market Share by Region (2021-2026)
Table 6. Charles River Corporate Information, Head Office, and Major Competitors
Table 7. Charles River Major Business
Table 8. Charles River Oncology Drug Discovery Services Product and Solutions
Table 9. Charles River Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Evotec Corporate Information, Head Office, and Major Competitors
Table 11. Evotec Major Business
Table 12. Evotec Oncology Drug Discovery Services Product and Solutions
Table 13. Evotec Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GE Healthcare Life Sciences Corporate Information, Head Office, and Major Competitors
Table 15. GE Healthcare Life Sciences Major Business
Table 16. GE Healthcare Life Sciences Oncology Drug Discovery Services Product and Solutions
Table 17. GE Healthcare Life Sciences Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. GenScript Corporate Information, Head Office, and Major Competitors
Table 19. GenScript Major Business
Table 20. GenScript Oncology Drug Discovery Services Product and Solutions
Table 21. GenScript Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Horizon Discovery Corporate Information, Head Office, and Major Competitors
Table 23. Horizon Discovery Major Business
Table 24. Horizon Discovery Oncology Drug Discovery Services Product and Solutions
Table 25. Horizon Discovery Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. TCG Lifesciences Corporate Information, Head Office, and Major Competitors
Table 27. TCG Lifesciences Major Business
Table 28. TCG Lifesciences Oncology Drug Discovery Services Product and Solutions
Table 29. TCG Lifesciences Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Zumutor Corporate Information, Head Office, and Major Competitors
Table 31. Zumutor Major Business
Table 32. Zumutor Oncology Drug Discovery Services Product and Solutions
Table 33. Zumutor Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. ChemPartner Corporate Information, Head Office, and Major Competitors
Table 35. ChemPartner Major Business
Table 36. ChemPartner Oncology Drug Discovery Services Product and Solutions
Table 37. ChemPartner Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Aquila BioMedical Corporate Information, Head Office, and Major Competitors
Table 39. Aquila BioMedical Major Business
Table 40. Aquila BioMedical Oncology Drug Discovery Services Product and Solutions
Table 41. Aquila BioMedical Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Onconova Corporate Information, Head Office, and Major Competitors
Table 43. Onconova Major Business
Table 44. Onconova Oncology Drug Discovery Services Product and Solutions
Table 45. Onconova Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Vichem Chemie Corporate Information, Head Office, and Major Competitors
Table 47. Vichem Chemie Major Business
Table 48. Vichem Chemie Oncology Drug Discovery Services Product and Solutions
Table 49. Vichem Chemie Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. GVK Biosciences Corporate Information, Head Office, and Major Competitors
Table 51. GVK Biosciences Major Business
Table 52. GVK Biosciences Oncology Drug Discovery Services Product and Solutions
Table 53. GVK Biosciences Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. NuChem Therapeutics Corporate Information, Head Office, and Major Competitors
Table 55. NuChem Therapeutics Major Business
Table 56. NuChem Therapeutics Oncology Drug Discovery Services Product and Solutions
Table 57. NuChem Therapeutics Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Syncom Corporate Information, Head Office, and Major Competitors
Table 59. Syncom Major Business
Table 60. Syncom Oncology Drug Discovery Services Product and Solutions
Table 61. Syncom Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Envigo Corporate Information, Head Office, and Major Competitors
Table 63. Envigo Major Business
Table 64. Envigo Oncology Drug Discovery Services Product and Solutions
Table 65. Envigo Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. DiverChim Corporate Information, Head Office, and Major Competitors
Table 67. DiverChim Major Business
Table 68. DiverChim Oncology Drug Discovery Services Product and Solutions
Table 69. DiverChim Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Aurora Corporate Information, Head Office, and Major Competitors
Table 71. Aurora Major Business
Table 72. Aurora Oncology Drug Discovery Services Product and Solutions
Table 73. Aurora Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. HD Biosciences Corporate Information, Head Office, and Major Competitors
Table 75. HD Biosciences Major Business
Table 76. HD Biosciences Oncology Drug Discovery Services Product and Solutions
Table 77. HD Biosciences Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. WuXi AppTec Corporate Information, Head Office, and Major Competitors
Table 79. WuXi AppTec Major Business
Table 80. WuXi AppTec Oncology Drug Discovery Services Product and Solutions
Table 81. WuXi AppTec Oncology Drug Discovery Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Global Oncology Drug Discovery Services Revenue (USD Million) by Players (2019-2021)
Table 83. Global Oncology Drug Discovery Services Revenue Share by Players (2019-2021)
Table 84. Breakdown of Oncology Drug Discovery Services by Company Type (Tier 1, Tier 2 and Tier 3)
Table 85. Oncology Drug Discovery Services Players Head Office, Products and Services Provided
Table 86. Oncology Drug Discovery Services Mergers & Acquisitions in the Past Five Years
Table 87. Oncology Drug Discovery Services New Entrants and Expansion Plans
Table 88. Global Oncology Drug Discovery Services Revenue (USD Million) by Type (2016-2021)
Table 89. Global Oncology Drug Discovery Services Revenue Share by Type (2016-2021)
Table 90. Global Oncology Drug Discovery Services Revenue Forecast by Type (2021-2026)
Table 91. Global Oncology Drug Discovery Services Revenue by Application (2016-2021)
Table 92. Global Oncology Drug Discovery Services Revenue Forecast by Application (2021-2026)
Table 93. North America Oncology Drug Discovery Services Revenue by Type (2016-2021) & (USD Million)
Table 94. North America Oncology Drug Discovery Services Revenue by Type (2021-2026) & (USD Million)
Table 95. North America Oncology Drug Discovery Services Revenue by Application (2016-2021) & (USD Million)
Table 96. North America Oncology Drug Discovery Services Revenue by Application (2021-2026) & (USD Million)
Table 97. North America Oncology Drug Discovery Services Revenue by Country (2016-2021) & (USD Million)
Table 98. North America Oncology Drug Discovery Services Revenue by Country (2021-2026) & (USD Million)
Table 99. Europe Oncology Drug Discovery Services Revenue by Type (2016-2021) & (USD Million)
Table 100. Europe Oncology Drug Discovery Services Revenue by Type (2021-2026) & (USD Million)
Table 101. Europe Oncology Drug Discovery Services Revenue by Application (2016-2021) & (USD Million)
Table 102. Europe Oncology Drug Discovery Services Revenue by Application (2021-2026) & (USD Million)
Table 103. Europe Oncology Drug Discovery Services Revenue by Country (2016-2021) & (USD Million)
Table 104. Europe Oncology Drug Discovery Services Revenue by Country (2021-2026) & (USD Million)
Table 105. Asia-Pacific Oncology Drug Discovery Services Revenue by Type (2016-2021) & (USD Million)
Table 106. Asia-Pacific Oncology Drug Discovery Services Revenue by Type (2021-2026) & (USD Million)
Table 107. Asia-Pacific Oncology Drug Discovery Services Revenue by Application (2016-2021) & (USD Million)
Table 108. Asia-Pacific Oncology Drug Discovery Services Revenue by Application (2021-2026) & (USD Million)
Table 109. Asia-Pacific Oncology Drug Discovery Services Revenue by Region (2016-2021) & (USD Million)
Table 110. Asia-Pacific Oncology Drug Discovery Services Revenue by Region (2021-2026) & (USD Million)
Table 111. South America Oncology Drug Discovery Services Revenue by Type (2016-2021) & (USD Million)
Table 112. South America Oncology Drug Discovery Services Revenue by Type (2021-2026) & (USD Million)
Table 113. South America Oncology Drug Discovery Services Revenue by Application (2016-2021) & (USD Million)
Table 114. South America Oncology Drug Discovery Services Revenue by Application (2021-2026) & (USD Million)
Table 115. South America Oncology Drug Discovery Services Revenue by Country (2016-2021) & (USD Million)
Table 116. South America Oncology Drug Discovery Services Revenue by Country (2021-2026) & (USD Million)
Table 117. Middle East & Africa Oncology Drug Discovery Services Revenue by Type (2016-2021) & (USD Million)
Table 118. Middle East & Africa Oncology Drug Discovery Services Revenue by Type (2021-2026) & (USD Million)
Table 119. Middle East & Africa Oncology Drug Discovery Services Revenue by Application (2016-2021) & (USD Million)
Table 120. Middle East & Africa Oncology Drug Discovery Services Revenue by Application (2021-2026) & (USD Million)
Table 121. Middle East & Africa Oncology Drug Discovery Services Revenue by Country (2016-2021) & (USD Million)
Table 122. Middle East & Africa Oncology Drug Discovery Services Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Oncology Drug Discovery Services Picture
Figure 2. Global Oncology Drug Discovery Services Revenue Market Share by Type in 2020
Figure 3. Identification Service
Figure 4. Authentication Service
Figure 5. Hit-to-lead and Lead Optimization Services
Figure 6. Others
Figure 7. Oncology Drug Discovery Services Revenue Market Share by Application in 2020
Figure 8. Research Institutes Picture
Figure 9. Pharmaceutical Companies Picture
Figure 10. Biotechnology Companies Picture
Figure 11. Others Picture
Figure 12. Global Oncology Drug Discovery Services Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Oncology Drug Discovery Services Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Oncology Drug Discovery Services Revenue Market Share by Region (2016-2026)
Figure 15. Global Oncology Drug Discovery Services Revenue Market Share by Region in 2020
Figure 16. North America Oncology Drug Discovery Services Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Oncology Drug Discovery Services Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Oncology Drug Discovery Services Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Oncology Drug Discovery Services Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Oncology Drug Discovery Services Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Oncology Drug Discovery Services Market Drivers
Figure 22. Oncology Drug Discovery Services Market Restraints
Figure 23. Oncology Drug Discovery Services Market Trends
Figure 24. Charles River Recent Developments and Future Plans
Figure 25. Evotec Recent Developments and Future Plans
Figure 26. GE Healthcare Life Sciences Recent Developments and Future Plans
Figure 27. GenScript Recent Developments and Future Plans
Figure 28. Horizon Discovery Recent Developments and Future Plans
Figure 29. TCG Lifesciences Recent Developments and Future Plans
Figure 30. Zumutor Recent Developments and Future Plans
Figure 31. ChemPartner Recent Developments and Future Plans
Figure 32. Aquila BioMedical Recent Developments and Future Plans
Figure 33. Onconova Recent Developments and Future Plans
Figure 34. Vichem Chemie Recent Developments and Future Plans
Figure 35. GVK Biosciences Recent Developments and Future Plans
Figure 36. NuChem Therapeutics Recent Developments and Future Plans
Figure 37. Syncom Recent Developments and Future Plans
Figure 38. Envigo Recent Developments and Future Plans
Figure 39. DiverChim Recent Developments and Future Plans
Figure 40. Aurora Recent Developments and Future Plans
Figure 41. HD Biosciences Recent Developments and Future Plans
Figure 42. WuXi AppTec Recent Developments and Future Plans
Figure 43. Global Oncology Drug Discovery Services Revenue Share by Players in 2020
Figure 44. Oncology Drug Discovery Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 45. Global Top 3 Players Oncology Drug Discovery Services Revenue Market Share in 2020
Figure 46. Global Top 10 Players Oncology Drug Discovery Services Revenue Market Share in 2020
Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 48. Global Oncology Drug Discovery Services Revenue Share by Type in 2020
Figure 49. Global Oncology Drug Discovery Services Market Share Forecast by Type (2021-2026)
Figure 50. Global Oncology Drug Discovery Services Revenue Share by Application in 2020
Figure 51. Global Oncology Drug Discovery Services Market Share Forecast by Application (2021-2026)
Figure 52. North America Oncology Drug Discovery Services Sales Market Share by Type (2016-2026)
Figure 53. North America Oncology Drug Discovery Services Sales Market Share by Application (2016-2026)
Figure 54. North America Oncology Drug Discovery Services Revenue Market Share by Country (2016-2026)
Figure 55. United States Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Canada Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Mexico Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Europe Oncology Drug Discovery Services Sales Market Share by Type (2016-2026)
Figure 59. Europe Oncology Drug Discovery Services Sales Market Share by Application (2016-2026)
Figure 60. Europe Oncology Drug Discovery Services Revenue Market Share by Country (2016-2026)
Figure 61. Germany Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. France Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. United Kingdom Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Russia Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Italy Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Asia-Pacific Oncology Drug Discovery Services Sales Market Share by Type (2016-2026)
Figure 67. Asia-Pacific Oncology Drug Discovery Services Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Oncology Drug Discovery Services Revenue Market Share by Region (2016-2026)
Figure 69. China Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Japan Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South Korea Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. India Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Southeast Asia Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Australia Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South America Oncology Drug Discovery Services Sales Market Share by Type (2016-2026)
Figure 76. South America Oncology Drug Discovery Services Sales Market Share by Application (2016-2026)
Figure 77. South America Oncology Drug Discovery Services Revenue Market Share by Country (2016-2026)
Figure 78. Brazil Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Argentina Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Middle East and Africa Oncology Drug Discovery Services Sales Market Share by Type (2016-2026)
Figure 81. Middle East and Africa Oncology Drug Discovery Services Sales Market Share by Application (2016-2026)
Figure 82. Middle East and Africa Oncology Drug Discovery Services Revenue Market Share by Country (2016-2026)
Figure 83. Turkey Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Saudi Arabia Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. UAE Oncology Drug Discovery Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. Methodology
Figure 87. Research Process and Data Source
世界の創薬におけるアウトソーシング市場 2021：企業別、地域別、種類・用途別 The Outsourcing in Drug Discovery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…- 世界の生物製剤創薬市場 2021：企業別、地域別、種類・用途別 The Biologics Drug Discovery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の創薬におけるクロマトグラフィー樹脂市場 2021：企業別、地域別、種類・用途別 The Chromatography Resin in Drug Discovery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 世界のシャルコー・マリー・トゥース病I型A型治療薬市場 2021：企業別、地域別、種類・用途別 The Charcot-Marie-Tooth Disease Type I A Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界の橋膠腫治療薬市場 2021：企業別、地域別、種類・用途別 The Pontine Glioma Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…